20 September 2019
Researchers from the Department of Medical Genetics and more than fifty researchers and practitioners from more than 34 organisations across Europe recently discussed the progress and results of the European Union project called “Joint Action on Rare Cancers” (JARC) in Belgium. The project is funded by the European Commission's Horizon 2020 programme.
The closing meeting of the JARC project was held in mid-September in Brussels where the participants and the invited guests received a summary book, which will also be downloadable from the following website:
The experts have come up with a 10-point message about rare cancers:
Along these points, researchers, experts and policymakers will work together to coordinate diagnostics and care on a national level, so that citizens with these rare diseases can receive support.
Dr. Béla Melegh, +36-72-501500/36427, firstname.lastname@example.org